April 24, 2026

POSITIVE Trial Update: Oncologic Outcomes Maintained After Pausing Endocrine Therapy for Pregnancy

For years, the question of pregnancy after, or during treatment for, hormone receptor–positive breast cancer placed patients and their oncologists in an uncomfortable position. Endocrine therapy, pres...

The ASCO Post

April 17, 2026

Radiology Groups Push Back on New Cancer Screening Guidelines

Radiology groups say the ACP's new screening recommendations conflict with nearly every major cancer organization and could cost thousands of lives annually.

Conexiant

March 24, 2026

How the Outlook on Fertility Preservation for Patients With Cancer Is Improving

Each year in the United States, about 90,000 adolescents and young adults (AYAs), ages 15 to 39, are diagnosed with cancer,1 and they are immediately faced with myriad challenges and disruptions in th...

The ASCO Post

March 05, 2026

Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence

Short-term exposure to low-dose vaginal estrogen therapy may relieve some symptoms of menopause for younger survivors of endometrial cancer without increasing the risk of endometrial cancer recurrence...

The ASCO Post

February 27, 2026

Cervical Cancer Is Preventable – So Why Do We Miss It?

A gynecologic oncologist explores new diagnostic priorities

The Pathologist

February 26, 2026

How the Outlook on Fertility Preservation for Patients With Cancer Is Improving

Each year in the United States, about 90,000 adolescents and young adults (AYAs), ages 15 to 39, are diagnosed with cancer,1 and they are immediately faced with myriad challenges and disruptions in th...

The ASCO Post

February 11, 2026

Fetal Spina Bifida Surgery Advances: Fewer Risks, Better Outcomes

At the Fetal Care Center, WashU Medicine surgeons perform both open and fetoscopic myelomeningocele repair, offering families results that exceed benchmarks

Barnes-Jewish

February 09, 2026

HPV Testing During Cervical Cancer Screening: Potential ‘Convenient and Noninvasive’ Method

Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, according to findings from a Chinese study.

The ASCO Post

January 28, 2026

Researchers Advance Understanding of Female Sexual Anatomy to Improve Pelvic Cancer Radiotherapy

A recent, innovative study offers practical guidance to identify and protect female sexual organs during pelvic cancer treatment, addressing a long-standing gap in cancer care by bringing key female s...

The ASCO Post

January 22, 2026

ACS Guidelines for Cervical Cancer

Self-collection of vaginal samples for human papillomavirus (HPV) testing is now being considered an acceptable, recommended option for cervical cancer screening, per recent updates to the American Ca...

The ASCO Post